Barclays’s Dermira, Inc. DERM Stock Holding History

Barclays’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$139K	–	7502
2017 Q4	$139K	Buy	+5,000	New	+$133K	﹤0.01%	4987
2017 Q1	–	Sell	-19,600	Closed	-$594K	–	7105
2016 Q4	$594K	Buy	+19,600	New	+$632K	﹤0.01%	3215
2016 Q3	–	Sell	-50,000	Closed	-$1.46M	–	6904
2016 Q2	$1.46M	Buy	+50,000	New	+$1.38M	﹤0.01%	2275

Barclays's DERM Position: Q1 2020 in Review

Barclays sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 218,797 shares — an estimated $3.32M sold.

Barclays first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $3.42M in Q2 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Barclays reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Barclays sold 218,797 Dermira, Inc. shares in Q1 2020, an estimated $3.32M.
Barclays first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
Barclays's Dermira, Inc. position peaked at $3.42M in Q2 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.